See more : Globus Power Generation Limited (GLOBUSCON.BO) Income Statement Analysis – Financial Results
Complete financial analysis of 1933 Industries Inc. (TGIFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1933 Industries Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Splendid Metal Products Limited (SMPL.NS) Income Statement Analysis – Financial Results
- KCTech Co., Ltd. (281820.KS) Income Statement Analysis – Financial Results
- OXIDE Corporation (6521.T) Income Statement Analysis – Financial Results
- Jet Freight Logistics Limited (JETFREIGHT.BO) Income Statement Analysis – Financial Results
- Webster Financial Corporation (WBS-PG) Income Statement Analysis – Financial Results
1933 Industries Inc. (TGIFF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.1933industries.com
About 1933 Industries Inc.
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in the medical and recreational cannabis sectors. The company also offers cannabidiol (CBD) infused products, such as vape pens, cartridges, lotions, lip balms, hemp seed oils, edible products, topical and dietary supplements, cosmetics, tinctures, sauces, vaporizers, drink additives, baking items, sweeteners, capsules, and tetrahydrocannabinol concentrates under the Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands. In addition, it provides cannabis flowers and concentrates. 1933 Industries Inc. offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.27M | 12.54M | 11.98M | 11.96M | 18.06M | 12.65M | 1.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
Cost of Revenue | 22.50M | 9.85M | 7.16M | 9.68M | 12.76M | 6.20M | 799.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -4.22M | 2.69M | 4.82M | 2.28M | 5.30M | 6.45M | 230.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 2.66K |
Gross Profit Ratio | -23.12% | 21.46% | 40.25% | 19.10% | 29.33% | 50.99% | 22.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.02M | 6.63M | 7.59M | 14.70M | 13.25M | 8.17M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
Selling & Marketing | 1.11M | 575.71K | 351.01K | 2.04M | 1.37M | 671.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.13M | 7.21M | 7.94M | 16.73M | 14.62M | 8.84M | 2.58M | 3.67M | 40.84K | 92.04K | 84.71K | 153.19K | 478.67K | 151.97K | 61.48K | 32.37K |
Other Expenses | 0.00 | 193.42K | 298.01K | 185.33K | 0.00 | -565.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | -602.76K | 7.71M | 8.44M | 18.92M | 15.27M | 9.12M | 2.60M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
Cost & Expenses | 27.62M | 17.56M | 15.60M | 28.60M | 28.03M | 15.32M | 3.40M | 3.67M | 40.84K | 92.04K | 84.97K | 154.21K | 567.78K | 152.18K | 61.48K | 32.37K |
Interest Income | 0.00 | 16.49K | 2.11M | 3.70M | 2.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.00 | 409.00 | 0.00 |
Interest Expense | 1.72M | 1.76M | 2.11M | 3.70M | 2.79M | 842.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.69M | 1.92M | 993.31K | 2.19M | 648.97K | 278.61K | 13.53K | 1.70M | 163.37K | -3.50K | 255.00 | 1.02K | 716.00 | 208.00 | 0.00 | 0.00 |
EBITDA | -10.03M | -2.88M | -2.71M | -14.26M | -9.32M | -2.87M | -2.53M | 0.00 | 0.00 | -95.54K | 860.74K | -95.96K | -567.06K | -151.80K | -61.07K | -29.71K |
EBITDA Ratio | -54.91% | -23.01% | -19.45% | -120.77% | -51.60% | -23.39% | -228.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,742.77% | -14,931.78% | -1,119.06% |
Operating Income | -9.35M | -4.81M | -3.32M | -16.63M | -9.97M | -3.24M | -2.55M | -3.67M | -40.84K | -92.04K | -1.03M | -211.44K | -567.78K | -152.00K | -61.07K | -29.71K |
Operating Income Ratio | -51.16% | -38.35% | -27.74% | -139.04% | -55.20% | -25.59% | -247.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
Total Other Income/Expenses | -4.09M | -12.71M | -2.48M | -3.51M | -9.68M | -1.96M | -193.25K | 0.00 | 0.00 | 3.50K | 0.00 | 0.00 | 0.00 | 0.00 | 61.07K | 29.71K |
Income Before Tax | -13.44M | -17.52M | -5.81M | -20.15M | -19.65M | -4.31M | -2.55M | -3.67M | -40.84K | -88.54K | -1.03M | -211.44K | -567.78K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -73.57% | -139.71% | -48.48% | -168.40% | -108.79% | -34.08% | -247.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 515.53K | 549.00K | 482.00K | -128.05K | -1.11M | 1.18M | 67.08K | -3.67M | -163.37K | 0.00 | 945.46K | -55.54K | -3.62K | 0.00 | 61.07K | 29.71K |
Net Income | -13.36M | -17.81M | -6.47M | -21.54M | -18.79M | -5.84M | -2.73M | -3.67M | -40.84K | -88.54K | -1.03M | -155.90K | -564.16K | -152.00K | -61.07K | -29.71K |
Net Income Ratio | -73.13% | -142.02% | -54.03% | -180.08% | -104.03% | -46.20% | -265.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87,863.01% | -14,931.78% | -1,119.06% |
EPS | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
EPS Diluted | -0.03 | -0.04 | -0.02 | -0.08 | -0.07 | -0.03 | -0.06 | -0.21 | -0.01 | -0.05 | -0.67 | -0.12 | -0.47 | -0.29 | -0.61 | -0.58 |
Weighted Avg Shares Out | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
Weighted Avg Shares Out (Dil) | 455.69M | 450.68M | 387.01M | 286.37M | 252.12M | 192.47M | 45.70M | 17.83M | 3.33M | 1.83M | 1.54M | 1.26M | 1.20M | 515.47K | 100.00K | 51.63K |
1933 Industries to Trade on the Pink Open Market
1933 Industries Announces Board Resignation
1933 Industries Reports Profit in Q3 2024 Financials
1933 Industries Announces Non-Brokered Private Placement
1933 Industries Extends Expiry Date of Warrants
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
1933 Industries Pauses CBD Manufacturing Division
1933 Industries Issues Correction
1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
Source: https://incomestatements.info
Category: Stock Reports